Immunic reported $-23.33M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
BioMarin Pharmaceutical USD 205.6M 100M Sep/2026
Cipla INR 10.43B 1.55B Sep/2026
Clal Biotechnology ILS -5.44M 3.76M Dec/2022
Compugen USD -8.84M 180K Jun/2026
CSL USD 2.64B 116M Dec/2025
Enanta Pharmaceuticals USD -23.54M 6.31M Dec/2024
Grifols EUR 320.55M 91.01M Dec/2025
Immunic USD -23.33M 2.67M Dec/2025
Insmed USD -81.83M 19.48M Sep/2026
Omeros USD -48.15M 7.25M Sep/2023
OraSure Technologies USD -13.59M 2.13M Dec/2025
Quidel USD 12.1M 27.4M Sep/2026
Ultragenyx Pharmaceutical USD -110M 35M Sep/2026
United Therapeutics USD 241.3M 134.3M Sep/2026